These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 1337402

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of cofactor effect of feline syncytium-forming virus on feline immunodeficiency virus infection.
    Zenger E, Brown WC, Song W, Wolf AM, Pedersen NC, Longnecker M, Li J, Collisson EW.
    Am J Vet Res; 1993 May; 54(5):713-8. PubMed ID: 8391229
    [Abstract] [Full Text] [Related]

  • 29. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats.
    Dean GA, LaVoy A, Yearley J, Stanton C.
    J Infect Dis; 2006 Jun 01; 193(11):1520-7. PubMed ID: 16652280
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.
    Finerty S, Stokes CR, Gruffydd-Jones TJ, Hillman TJ, Barr FJ, Harbour DA.
    Vaccine; 2001 Oct 12; 20(1-2):49-58. PubMed ID: 11567745
    [Abstract] [Full Text] [Related]

  • 34. Macrophage functions in cats experimentally infected with feline immunodeficiency virus and Toxoplasma gondii.
    Lin DS, Bowman DD.
    Vet Immunol Immunopathol; 1992 Jun 12; 33(1-2):69-78. PubMed ID: 1321533
    [Abstract] [Full Text] [Related]

  • 35. Effect of primary phase feline immunodeficiency virus infection on cats with chronic toxoplasmosis.
    Lappin MR, Gasper PW, Rose BJ, Powell CC.
    Vet Immunol Immunopathol; 1992 Dec 12; 35(1-2):121-31. PubMed ID: 1363007
    [Abstract] [Full Text] [Related]

  • 36. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
    Hohdatsu T, Sasagawa T, Yamazaki A, Motokawa K, Kusuhara H, Kaneshima T, Koyama H.
    Arch Virol; 2002 Aug 12; 147(8):1517-29. PubMed ID: 12181672
    [Abstract] [Full Text] [Related]

  • 37. Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats.
    Gebhard DH, Dow JL, Childers TA, Alvelo JI, Tompkins MB, Tompkins WA.
    J Infect Dis; 1999 Nov 12; 180(5):1503-13. PubMed ID: 10515809
    [Abstract] [Full Text] [Related]

  • 38. Programmed cell death (apoptosis) as a mechanism of cell death in peripheral blood mononuclear cells from cats infected with feline immunodeficiency virus (FIV).
    Bishop SA, Gruffydd-Jones TJ, Harbour DA, Stokes CR.
    Clin Exp Immunol; 1993 Jul 12; 93(1):65-71. PubMed ID: 8391941
    [Abstract] [Full Text] [Related]

  • 39. [Vaccination of cats against infection with feline leukemia virus (FeLV): first recombinant vaccine and the effect of a pre-existing infection with feline immunodeficiency virus (FIV)].
    Hofmann-Lehmann R, Aubert A, Wolfensberger C, Cronier J, Lutz H.
    Schweiz Arch Tierheilkd; 1994 Jul 12; 136(10):340-51. PubMed ID: 7801087
    [Abstract] [Full Text] [Related]

  • 40. Long-term clinical observations on feline immunodeficiency virus infected asymptomatic carriers.
    Ishida T, Taniguchi A, Matsumura S, Washizu T, Tomoda I.
    Vet Immunol Immunopathol; 1992 Dec 12; 35(1-2):15-22. PubMed ID: 1337394
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.